Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin A Olenchock

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Nature Communications|May 26, 2021
Sulfide catabolism ameliorates hypoxic brain injuryEizo Marutani, Masanobu Morita, Shuichi Hirai, et al.
Cell|September 18, 2018
Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in GliomaSamuel K McBrayer, Jared R Mayers, Gabriel J DiNatale, et al.
The Lancet. Infectious Diseases|September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trialFlonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
The New England Journal of Medicine|November 3, 2016
Fulminant Myocarditis with Combination Immune Checkpoint BlockadeDouglas B Johnson, Justin M Balko, Margaret L Compton, et al.
Science Translational Medicine|December 4, 2024
Diverse NKT cells regulate early inflammation and neurological outcomes after cardiac arrest and resuscitationTomoyoshi Tamura, Changde Cheng, Ana B Villaseñor-Altamirano, et al.
Science Translational Medicine|November 22, 2023
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiencyJudith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska, et al.
Nature|September 11, 2024
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular toneMichael E Dunn, Aaron Kithcart, Jee Hae Kim, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nature Communications|May 26, 2021
Sulfide catabolism ameliorates hypoxic brain injuryEizo Marutani, Masanobu Morita, Shuichi Hirai, et al.
Cell|September 18, 2018
Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in GliomaSamuel K McBrayer, Jared R Mayers, Gabriel J DiNatale, et al.
The Lancet. Infectious Diseases|September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trialFlonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
The New England Journal of Medicine|November 3, 2016
Fulminant Myocarditis with Combination Immune Checkpoint BlockadeDouglas B Johnson, Justin M Balko, Margaret L Compton, et al.
Science Translational Medicine|December 4, 2024
Diverse NKT cells regulate early inflammation and neurological outcomes after cardiac arrest and resuscitationTomoyoshi Tamura, Changde Cheng, Ana B Villaseñor-Altamirano, et al.
Science Translational Medicine|November 22, 2023
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiencyJudith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska, et al.
Nature|September 11, 2024
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular toneMichael E Dunn, Aaron Kithcart, Jee Hae Kim, et al.
Pageof 4